| Neutropenia |
HSCT |
|||
|---|---|---|---|---|
| <10d (n = 97) | >10d (n = 101) | Autologous (n = 101) | Allogeneic (n = 100) | |
| Proportion of investigators estimating that patients are at high risk of bacterial infections | 9% | 78% | 51% | 80% |
| Proportion of patients receiving antibacterial Px | 19% | 51% | 50% | 76% |
| Antibiotics used for Px: | ||||
| Ciprofloxacin | 55% | 52% | 56% | 53% |
| Other fluoroquinolone | 19% | 20% | 18% | 22% |
| Cotrimoxazole | 23% | 15% | 18% | 22% |
| Selective digestive decontamination | 3% | 10% | 7% | 11% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.